Methylene Blue Dosage: What Research Shows (mg/kg by Weight)

Methylene blue is one of the most-studied small molecules in pharmacology, with research stretching back over 130 years. One of the most common questions in the literature — and in the broader research community exploring methylene blue's cognitive and mitochondrial properties — is what doses have actually been examined in studies. This article reviews the dosage ranges documented in published research and biohacker community protocols, along with the cycling schedules, timing, and contraindications described in the literature.

On stacking with caffeine, see methylene blue and caffeine timing.

For exercise-specific timing, see methylene blue and exercise.

Common questions: see how methylene blue tastes.

For the underlying mechanism that informs these protocols, see how methylene blue works in cellular energy and brain function.

Important: Methylene blue has documented interactions with several medications, especially serotonergic drugs (SSRIs, SNRIs, MAOIs). See our full breakdown of methylene blue drug interactions before combining with any prescription medication.

Wondering about the legal status? legal status in Canada — see our full breakdown of Health Canada's regulatory position and what it means for buyers.

Nothing in this article should be interpreted as medical advice or a recommendation to self-administer. Methylene blue is sold by Perfect Blue Labs for research and laboratory purposes. Anyone considering personal use should consult a qualified healthcare professional.

---

---

The Principle Documented Across the Research

One principle appears consistently in both the published literature and biohacker community protocols: methylene blue is studied and used at the lowest effective dose, with gradual incremental adjustments. This pattern reflects the well-documented biphasic dose-response of methylene blue.

Research has shown that methylene blue follows a hormetic dose-response curve — low doses tend to produce stimulating, cognitive-supportive effects, while very high doses can produce the opposite effect on mitochondrial function. This biphasic behavior is one of the reasons precise concentration matters in any methylene blue research context.

Dosage Ranges Reported in the Literature

Low-Dose Range — Cognitive Research Protocols

This is the range most commonly examined in cognitive and mood-related research, and described in community-documented protocols:

• Reported range: 0.5 mg/kg to 1 mg/kg of body weight
• For a 70 kg (154 lb) reference subject: approximately 35–70 mg
• Effects reported in studies: improved mental clarity, enhanced focus, memory consolidation, increased energy
• Timing in protocols: typically morning administration to avoid sleep interference

Mid-Dose Range — Mitochondrial Research Protocols

Higher doses have been examined in research focused on mitochondrial function:

• Reported range: 1 mg/kg to 2 mg/kg of body weight
• For a 70 kg subject: approximately 70–140 mg
• Effects documented: enhanced cellular energy markers, more pronounced cognitive effects, mood elevation in some studies
• Note: at this range, transient blue-green urine has been reported in the literature — a benign and expected pharmacokinetic observation

What the Research Suggests About Higher Doses

Doses above 4 mg/kg have shown diminishing returns and increased adverse-effect frequency in published studies. Very high doses (above 10 mg/kg) have been documented to inhibit mitochondrial function — the inverse of the low-dose effect. This is why the published research on methylene blue concentrates almost exclusively on the low-to-medium range described above.

Dose by Body Weight — Reference Table

This reference table summarizes the doses commonly examined in the cognitive-research range (0.5–1 mg/kg) for a range of body weights:

Body Weight	Low-Range (0.5 mg/kg)	Standard-Range (1 mg/kg)	mL of 2% Solution
50 kg (110 lb)	25 mg	50 mg	1.25 – 2.5 mL
65 kg (143 lb)	32 mg	65 mg	1.6 – 3.25 mL
70 kg (154 lb)	35 mg	70 mg	1.75 – 3.5 mL
80 kg (176 lb)	40 mg	80 mg	2.0 – 4.0 mL
90 kg (198 lb)	45 mg	90 mg	2.25 – 4.5 mL
100 kg (220 lb)	50 mg	100 mg	2.5 – 5.0 mL

Initial Assessment vs. Established Protocols

Initial Assessment Phase (First 1–2 Weeks)

Studies and community-documented protocols treat the first two weeks as an assessment window:

• Starting reference dose: 0.5 mg/kg, once daily, morning administration
• Cycling pattern: 5 days on, 2 days off
• Self-monitoring: changes in energy, focus, sleep quality, and any adverse effects
• Doses are typically not adjusted during this phase

Established Protocols (Week 3 Onward)

After an initial baseline is established, the literature describes adjustment patterns such as:

• Increase to approximately 1 mg/kg if the starter dose was tolerated without adverse effects
• Continued cycling — 5 days on, 2 days off
• Reduction to 3–4 administrations per week for ongoing maintenance
• Reassessment every 4 weeks, with full one-week breaks taken monthly in long-term protocols

---

---

Calculating Doses With a 2% Solution

A 2% methylene blue solution contains 20 mg of methylene blue per mL. This makes calculation against the reference doses straightforward:

• Reference dose of 35 mg = 1.75 mL of 2% solution
• Reference dose of 50 mg = 2.5 mL of 2% solution
• Reference dose of 70 mg = 3.5 mL of 2% solution

Research protocols use 1 mL oral syringes or graduated droppers for accuracy. Visual estimation introduces variability that compromises study reproducibility.

Cycling Patterns Documented in the Literature

Research and biohacker community protocols rarely use methylene blue daily without breaks. The most commonly documented cycling pattern is 5 days on, 2 days off — typically aligned with weekday/weekend schedules.

The rationale documented in the literature: continuous daily administration may produce diminishing returns through receptor and pathway adaptation. Periodic breaks help preserve the compound's effects. Longer breaks of one full week every 4–6 weeks are also described as a longer reset interval.

Timing in Published Protocols

Timing patterns documented in the research and community literature:

• Morning administration is standard — methylene blue's mild stimulant effect can interfere with sleep when administered later in the day
• Food is generally optional — both fed and fasted administration appear in the literature; some sources note gentler GI tolerance with food
• High-dose vitamin C is typically separated — vitamin C can prematurely reduce methylene blue, lowering its bioavailability at target tissues
• Afternoon administration is uncommon — most documented protocols concentrate dosing before noon

Compounds Commonly Studied in Combination

Several compounds appear alongside methylene blue in published research and community protocols:

• Red and near-infrared light therapy — the most documented stack. Red light activates cytochrome c oxidase, the same mitochondrial enzyme methylene blue supports. The synergy is well represented in published research.
• Racetam-class compounds — racetams such as piracetam and aniracetam appear in community protocols for combined cognitive effects
• Omega-3 fatty acids — referenced for neuronal membrane support alongside methylene blue's mitochondrial activity
• NAD+ precursors — NMN and NR work on overlapping mitochondrial pathways and are commonly co-studied with methylene blue

Documented Contraindications

The published literature is clear that methylene blue is not appropriate in several contexts. The compound is generally excluded from research protocols, and is contraindicated for use, in individuals who:

• Are taking SSRIs, SNRIs, or MAOIs — methylene blue inhibits monoamine oxidase and can cause serotonin syndrome when combined with serotonergic medications
• Have a glucose-6-phosphate dehydrogenase (G6PD) deficiency
• Are pregnant or breastfeeding
• Are taking other medications sensitive to MAO inhibition

Anyone on prescription medications should consult a qualified healthcare professional before any methylene blue exposure.

Why Concentration Accuracy Matters in Research

Every protocol referenced above assumes the methylene blue solution is accurately concentrated. A bottle labeled 2% that is actually 1% would invalidate every calculation against the reference table. This is one reason published research uses pharmaceutical-grade material with verified concentration.

Perfect Blue Labs' 2% solution is made and bottled in Canada to consistent concentration standards, with clear labeling. Material at this quality grade is appropriate for any research context where accurate concentration matters.